NYSE:STEMedical Equipment
The Bull Case For STERIS (STE) Could Change Following Margin Pressures Amid Revenue Growth And Buybacks
In its most recent quarter ended December 31, 2025, STERIS plc reported higher sales of US$1,496.2 million and net income of US$192.9 million, alongside completing a US$350.6 million share repurchase program totaling 1,507,158 shares since May 2023.
The combination of rising earnings per share and ongoing margin pressure from tariffs and inflation highlights a tension between growth in profitability metrics and the cost environment facing STERIS.
We’ll now examine how STERIS’s margin...